These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9669295)

  • 1. Immunomodulatory treatment of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM
    Thyroid; 1998 Jun; 8(6):545-8. PubMed ID: 9669295
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of 3-stage treatment: (I) corticotherapy, (II) linear acceleration and (III) orbital decompression in 206 patients with malignant Graves ophthalmopathy].
    Zgliczyński S; Jastrzebska H; Górowski T; Janik J; Kuś J; Hliniak A; Karczmarzyk R; Kukołowicz P
    Endokrynol Pol; 1992; 43(3):274-86. PubMed ID: 1345567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical approach to ophthalmopathy of Graves' disease.
    Ivy HK
    Mayo Clin Proc; 1972 Dec; 47(12):980-5. PubMed ID: 4404646
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
    Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
    Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of endocrine ophthalmopathy].
    Pfannenstiel P; Utech C; Wulle KG
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1331-3. PubMed ID: 3755678
    [No Abstract]   [Full Text] [Related]  

  • 10. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with immunoglobulins in thyroid autoimmunity.
    Lecomte P; Labussière AS; Nduwayo L; Osorio-Salazar C; Lasfargues G; Diot E; Guilmot JL
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S103-7. PubMed ID: 8828956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Graves' ophthalmopathy with new immunosuppressive agents.
    Utech C; Wulle KG; Panitz N; Kiefer H
    Dev Ophthalmol; 1989; 20():94-9. PubMed ID: 2591632
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.
    Goswami R
    Acta Endocrinol (Copenh); 1992 May; 126(5):474. PubMed ID: 1621491
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of patients with Graves' orbitopathy treated by plasmapheresis and immunosuppression.
    Zielinski CC; Weissel M; Müller C; Till P; Höfer R
    Dev Ophthalmol; 1989; 20():130-8. PubMed ID: 2574116
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
    Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
    Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of plasmapheresis in Graves' ophthalmopathy.
    Glinoer D
    Exp Clin Endocrinol; 1991 May; 97(2-3):328-31. PubMed ID: 1915651
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.